Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 3Plasma cell 2Myeloid 1

Conditions

Lymphoma 152Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Follicular 81Lymphoma, Large B-Cell, Diffuse 80Leukemia 79Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Burkitt Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 63Lymphoma, Large-Cell, Immunoblastic 58Lymphoma, Mantle-Cell 53Lymphoma, B-Cell, Marginal Zone 52Myelodysplastic Syndromes 40Leukemia, Myeloid, Chronic-Phase 36Leukemia, Myeloid, Acute 36Dendritic Cell Sarcoma, Interdigitating 33Leukemia, Myeloid, Accelerated Phase 32Neoplasms, Plasma Cell 30Multiple Myeloma 30Recurrence 28Blast Crisis 23Myeloproliferative Disorders 22Congenital Abnormalities 21Leukemia, Myelomonocytic, Chronic 20Mycosis Fungoides 19Myelodysplastic-Myeloproliferative Diseases 17Lymphoma, Large-Cell, Anaplastic 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Graft vs Host Disease 17Waldenstrom Macroglobulinemia 16

Interventions

Cyclophosphamide 40fludarabine 36fludarabine phosphate 28Tacrolimus 20Whole-Body Irradiation 18Mycophenolic Acid 18Busulfan 18Melphalan 16thymoglobulin 14Rituximab 13Antilymphocyte Serum 12venetoclax 11Thiotepa 10Nivolumab 9Methotrexate 9Granulocyte Colony-Stimulating Factor 9Stem Cell Transplantation 8Peripheral Blood Stem Cell Transplantation 8Cyclosporine 8trametinib 7Sirolimus 7Cytarabine 7Azacitidine 7AP 1903 reagent 7Filgrastim 6Dexamethasone 6aldesleukin 5Mesna 5Ipilimumab 5Interleukin-2 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Radiotherapy × Lymphoid × Clear all
NCT04473937 2025-09-24

Radiation Post-CAR T in Refractory Lymphoma

Massachusetts General Hospital

Phase NA Terminated
3 enrolled 9 charts
LymphoidOther hematologic neoplasm

Lymphoma, Hematologic Neoplasms

NCT01350258 2025-05-31

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Thomas Jefferson University

Phase 1/2 Terminated
8 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01532635 2025-05-04

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Thomas Jefferson University

Phase 2 Terminated
4 enrolled 8 charts
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡